We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns OTC Drugmaker in India for GMP Violations
FDA Warns OTC Drugmaker in India for GMP Violations
The FDA issued a warning letter to an over-the-counter (OTC) drugmaker in Gujarat, India for serious violations of current good manufacturing practices.